Search Results - Pascal Pommier

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the C... by David Pasquier, Philippe Nickers, Didier Peiffert, Philippe Maingon, Pascal Pommier, Thomas Lacornerie, Emmanuelle Tresch, Maël Barthoulot, Eric Lartigau

    Published in European Urology Open Science (2023-08-01)
    Get full text
    Article


  2. 2

    Resident training in brachytherapy in France: A 10-year update after the first survey of SFJRO members by Manon Kissel, Luc Ollivier, Ingrid Fumagalli, Pascal Pommier, Cyrus Chargari, Pierre Blanchard, Didier Peiffert, Jean-Michel Hannoun-Levi

    Published in Journal of Contemporary Brachytherapy (2022-12-01)
    Get full text
    Article


  3. 3

    Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer by Ingrid Masson, Laurène Larriviere, Marc-André Mahé, David Azria, Pascal Pommier, Nathalie Mesgouez-Nebout, Philippe Giraud, Didier Peiffert, Bruno Chauvet, Philippe Dudouet, Naji Salem, Georges Noël, Jonathan Khalifa, Igor Latorzeff, Catherine Guérin-Charbonnel, Stéphane Supiot

    Get full text
    Article


  4. 4

    A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy – including photon and proton therapy – for the treatment of radio... by Jacques Balosso, Olivia Febvey-Combes, Annie Iung, Hélène Lozano, Abdoulkader Soumai Alloh, Catherine Cornu, Magali Hervé, Zohra Akkal, Michel Lièvre, Valérie Plattner, Francesca Valvo, Cristina Bono, Maria Rosaria Fiore, Viviana Vitolo, Barbara Vischioni, Stéphanie Patin, Hubert Allemand, François Gueyffier, Jennifer Margier, Pascale Guerre, Sylvie Chabaud, Roberto Orecchia, Pascal Pommier

    Published in BMC Cancer (2022-05-01)
    Get full text
    Article


  5. 5

    Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study... by Maximilien Rogé, Yoann Pointreau, Paul Sargos, Emmanuel Meyer, Ulrike Schick, Ali Hasbini, Emmanuel Rio, Guillaume Bera, Amandine Ruffier, Magali Quivrin, Mathieu Chasseray, Igor Latorzeff, Etienne Martin, Valentine Guimas, Pascal Pommier, Thomas Leroy, Philippe Ronchin, Alexis Lepinoy, Audrey Grand, Lysian Cartier, Ossama Didas, Fabrice Denis, Vincent Libois, Audrey Blanc-Lapierre, Stéphane Supiot

    Get full text
    Article


Search Tools: